NextCure, Inc. (NXTC) Tops Q3 EPS by 15c

NextCure, Inc. (NASDAQ: NXTC) reported Q3 EPS of ($0.51), $0.15 better than the analyst estimate of ($0.66).

For earnings history and earnings-related data on NextCure, Inc. (NXTC) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Independent Bank receives regulatory approval for HCB Financial acquisition
• Schwab's May activity shows margin loans nearly double